e-learning
resources
Virtual 2020
Pre-Congress Content
Occupational and environmental causes of respiratory disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
In former asbestos-exposed workers TCT findings are more highly correlated to DLCO than to vital capacity
A. Preisser (Hamburg, Germany), K. Schlemmer (Hamburg, Germany), R. Herold (Hamburg, Germany), A. Laqmani (Hamburg, Germany), C. Terschüren (Hamburg, Germany), V. Harth (Hamburg, Germany)
Source:
Virtual Congress 2020 – Occupational and environmental causes of respiratory disease
Session:
Occupational and environmental causes of respiratory disease
Session type:
E-poster session
Number:
3164
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Preisser (Hamburg, Germany), K. Schlemmer (Hamburg, Germany), R. Herold (Hamburg, Germany), A. Laqmani (Hamburg, Germany), C. Terschüren (Hamburg, Germany), V. Harth (Hamburg, Germany). In former asbestos-exposed workers TCT findings are more highly correlated to DLCO than to vital capacity. 3164
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Blood gas parameters at exercise are more sensitive for lung involvement in patients with SSc than DLCO
Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing
Year: 2010
The role of spirometry and ?arbon monoxide diffusing capacity (DLCO) in the diagnosis of pulmonary function in patients after COVID-19 pneumonia
Source: Virtual Congress 2021 – Pulmonary rehabilitation in the COVID-19 era
Year: 2021
Static lung compliance and DLCO often demonstrate parenchymal involvement in sarcoidosis despite a normal total lung capacity
Source: Annual Congress 2009 - Sarcoidosis in review
Year: 2009
CO-diffusion capacity in asbestos-exposed workers with or without abnormal chest X-ray findings
Source: Annual Congress 2011 - Mineral dusts
Year: 2011
An abnormal DLCO measurement
Source: Virtual Congress 2020 – Airway diseases
Year: 2020
Prevalence of abnormal lung volumes, DLCO and chest HRCT in smokers with normal spirometry
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013
Diurnal variation in forced vital capacity in patients with fibrotic interstitial lung disease using home spirometry: the DIVA study
Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia
Year: 2019
Roles of transthoracic lung ultrasonography in diagnosis of interstitial lung disease: correlation with HRCT, vital capacity, diffusing of the lung for monoxide test
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018
Percent predicted forced vital capacity (FVC) is a reliable, valid, and responsive measure of clinical status in patients with idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2010 - Clinical issues in idiopathic pulmonary fibrosis
Year: 2010
Distinguishing hyperinflation from combined restriction in patients with reduced FEV
1
/FVC and FVC on spirometry
Source: Eur Respir J 2006; 28: Suppl. 50, 202s
Year: 2006
Forced vital capacity, total lung capacity and diffusion capacity in idiopathic pulmonary fibrosis
Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Year: 2018
Monocyte count and decline in forced vital capacity (FVC) in patients with IPF
Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Year: 2020
Is inspiratory capacity (IC) better correlated with functional exercise capacity than FEV1 in COPD patients?
Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases
Year: 2012
Computer assisted HRCT analysis in IPF patients detects change in ground glass opacity despite stable forced vital capacity
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008
Lung function and radiological findings in a group of fibre-exposed asbestos workers
Source: Eur Respir J 2002; 20: Suppl. 38, 127s
Year: 2002
Exercise limitation in patients with interstitial lung disease independent from diffusion capacity (DLCO)
Source: Annual Congress 2008 - Exercise: system responses
Year: 2008
Investigation of lung involvement with DLCO in women exposed to biomass smoke
Source: Annual Congress 2012 - COPD beyond tobacco
Year: 2012
Spirometric evaluation of idiopathic pulmonary fibrosis (IPF): forced or slow vital capacity?
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019
Association of long-term air pollution with spirometry and lung diffusing capacity: Results from the KORA FF4 study
Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function
Year: 2017
CT scan derived emphysema scores correlate with spirometry and gas exchange but not acute exacerbation rates (AER) or COPD assessment test (CAT) in COPD subjects with and without alpha-1-antitrypsin (AAT) deficiency
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept